A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
02 2020
Historique:
received: 20 10 2018
accepted: 19 12 2019
pubmed: 16 2 2020
medline: 14 4 2020
entrez: 16 2 2020
Statut: ppublish

Résumé

In many repeat diseases, such as Huntington's disease (HD), ongoing repeat expansions in affected tissues contribute to disease onset, progression and severity. Inducing contractions of expanded repeats by exogenous agents is not yet possible. Traditional approaches would target proteins driving repeat mutations. Here we report a compound, naphthyridine-azaquinolone (NA), that specifically binds slipped-CAG DNA intermediates of expansion mutations, a previously unsuspected target. NA efficiently induces repeat contractions in HD patient cells as well as en masse contractions in medium spiny neurons of HD mouse striatum. Contractions are specific for the expanded allele, independently of DNA replication, require transcription across the coding CTG strand and arise by blocking repair of CAG slip-outs. NA-induced contractions depend on active expansions driven by MutSβ. NA injections in HD mouse striatum reduce mutant HTT protein aggregates, a biomarker of HD pathogenesis and severity. Repeat-structure-specific DNA ligands are a novel avenue to contract expanded repeats.

Identifiants

pubmed: 32060489
doi: 10.1038/s41588-019-0575-8
pii: 10.1038/s41588-019-0575-8
pmc: PMC7043212
mid: NIHMS1547031
doi:

Substances chimiques

HTT protein, human 0
Htt protein, mouse 0
Huntingtin Protein 0
Naphthyridines 0
Quinolones 0
TATA-Box Binding Protein 0
TBP protein, human 0
naphthyridine-azaquinolone 0
DNA 9007-49-2
Ribonucleases EC 3.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-159

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES014737
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG010169
Pays : United States
Organisme : CIHR
ID : FRN388879
Pays : Canada
Organisme : CIHR
ID : FRN148910
Pays : Canada

Commentaires et corrections

Type : CommentIn

Références

Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol. Genet. 12, 3359–3367 (2003).
doi: 10.1093/hmg/ddg352 pubmed: 14570710 pmcid: 14570710
Lopez Castel, A., Cleary, J. D. & Pearson, C. E. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell Biol. 11, 165–170 (2010).
doi: 10.1038/nrm2854 pubmed: 20177394 pmcid: 20177394
Mirkin, S. M. Expandable DNA repeats and human disease. Nature 447, 932–940 (2007).
doi: 10.1038/nature05977 pubmed: 17581576 pmcid: 17581576
Pearson, C. E., Nichol Edamura, K. & Cleary, J. D. Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6, 729–742 (2005).
doi: 10.1038/nrg1689 pubmed: 16205713 pmcid: 16205713
Sathasivam, K., Amaechi, I., Mangiarini, L. & Bates, G. Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage. Hum. Genet. 99, 692–695 (1997).
doi: 10.1007/s004390050432 pubmed: 9150744 pmcid: 9150744
Morales, F. et al. Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum. Mol. Genet. 21, 3558–3567 (2012).
doi: 10.1093/hmg/dds185 pubmed: 22595968 pmcid: 22595968
Swami, M. et al. Somatic expansion of the Huntington’s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum. Mol. Genet. 18, 3039–3047 (2009).
doi: 10.1093/hmg/ddp242 pubmed: 19465745 pmcid: 19465745
Bettencourt, C. et al. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Ann. Neurol. 79, 983–990 (2016).
doi: 10.1002/ana.24656 pubmed: 27044000 pmcid: 27044000
Genetic Modifiers of Huntington’s Disease Consortium Identification of genetic factors that modify clinical onset of Huntington’s disease. Cell 162, 516–526 (2015).
doi: 10.1016/j.cell.2015.07.003
Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington’s disease onset. Cell 178, 887–900.e14 (2019).
Hensman Moss, D. J. et al. Identification of genetic variants associated with Huntington’s disease progression: a genome-wide association study. Lancet Neurol. 16, 701–711 (2017).
doi: 10.1016/S1474-4422(17)30161-8
Gusella, J. F. & MacDonald, M. E. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1, 109–115 (2000).
doi: 10.1038/35039051 pubmed: 11252773 pmcid: 11252773
Rosenblatt, A. et al. Age, CAG repeat length, and clinical progression in Huntington’s disease. Mov. Disord. 27, 272–276 (2012).
doi: 10.1002/mds.24024 pubmed: 22173986 pmcid: 22173986
Axford, M. M. et al. Detection of slipped-DNAs at the trinucleotide repeats of the myotonic dystrophy type I disease locus in patient tissues. PLoS Genet. 9, e1003866 (2013).
doi: 10.1371/journal.pgen.1003866 pubmed: 24367268 pmcid: 24367268
Goula, A. V. et al. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington’s disease transgenic mice. PLoS Genet. 5, e1000749 (2009).
doi: 10.1371/journal.pgen.1000749 pubmed: 19997493 pmcid: 19997493
Lin, Y., Dent, S. Y., Wilson, J. H., Wells, R. D. & Napierala, M. R loops stimulate genetic instability of CTG·CAG repeats. Proc. Natl Acad. Sci. USA 107, 692–697 (2010).
doi: 10.1073/pnas.0909740107 pubmed: 20080737 pmcid: 20080737
Pearson, C. E. et al. Slipped-strand DNAs formed by long (CAG)·(CTG) repeats: slipped-out repeats and slip-out junctions. Nucleic Acids Res. 30, 4534–4547 (2002).
doi: 10.1093/nar/gkf572 pubmed: 12384601 pmcid: 12384601
Reddy, K. et al. Processing of double-R-loops in (CAG)·(CTG) and C9orf72 (GGGGCC)·(GGCCCC) repeats causes instability. Nucleic Acids Res. 42, 10473–10487 (2014).
doi: 10.1093/nar/gku658 pubmed: 25147206 pmcid: 25147206
Schmidt, M. H. & Pearson, C. E. Disease-associated repeat instability and mismatch repair. DNA Repair 38, 117–126 (2016).
doi: 10.1016/j.dnarep.2015.11.008 pubmed: 26774442 pmcid: 26774442
Tome, S. et al. Msh3 polymorphisms and protein levels affect CAG repeat instability in Huntington’s disease mice. PLoS Genet. 9, e1003280 (2013).
doi: 10.1371/journal.pgen.1003280 pubmed: 23468640 pmcid: 23468640
Nakamori, M., Pearson, C. E. & Thornton, C. A. Bidirectional transcription stimulates expansion and contraction of expanded (CTG)·(CAG) repeats. Hum. Mol. Genet. 20, 580–588 (2011).
doi: 10.1093/hmg/ddq501 pubmed: 21088112 pmcid: 21088112
Lin, Y. & Wilson, J. H. Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability. PLoS ONE 7, e46807 (2012).
doi: 10.1371/journal.pone.0046807 pubmed: 23056461 pmcid: 23056461
Panigrahi, G. B., Slean, M. M., Simard, J. P., Gileadi, O. & Pearson, C. E. Isolated short CTG/CAG DNA slip-outs are repaired efficiently by hMutSβ, but clustered slip-outs are poorly repaired. Proc. Natl Acad. Sci. USA 107, 12593–12598 (2010).
doi: 10.1073/pnas.0909087107 pubmed: 20571119 pmcid: 20571119
Hagihara, M. & Nakatani, K. Inhibition of DNA replication by a d(CAG) repeat binding ligand. Nucleic Acids Symp. Ser. 50, 147–148 (2006).
doi: 10.1093/nass/nrl073
Hagihara, M., He, H. & Nakatani, K. Small molecule modulates hairpin structures in CAG trinucleotide repeats. ChemBioChem 12, 1686–1689 (2011).
doi: 10.1002/cbic.201100260 pubmed: 21695756 pmcid: 21695756
Nakatani, K. et al. Small-molecule ligand induces nucleotide flipping in (CAG)n trinucleotide repeats. Nat. Chem. Biol. 1, 39–43 (2005).
doi: 10.1038/nchembio708 pubmed: 16407992 pmcid: 16407992
Nielsen, P. E., Zhen, W. P., Henriksen, U. & Buchardt, O. Sequence-influenced interactions of oligoacridines with DNA detected by retarded gel electrophoretic migrations. Biochemistry 27, 67–73 (1988).
doi: 10.1021/bi00401a012 pubmed: 2831963 pmcid: 2831963
Pluciennik, A. et al. Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutLα endonuclease activation. Proc. Natl Acad. Sci. USA 110, 12277–12282 (2013).
doi: 10.1073/pnas.1311325110 pubmed: 23840062 pmcid: 23840062
Shelbourne, P. F. et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum. Mol. Genet. 16, 1133–1142 (2007).
doi: 10.1093/hmg/ddm054 pubmed: 17409200 pmcid: 17409200
Silveira, I. et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch. Neurol. 59, 623–629 (2002).
doi: 10.1001/archneur.59.4.623 pubmed: 11939898 pmcid: 11939898
Sanchez-Contreras, M. & Cardozo-Pelaez, F. Age-related length variability of polymorphic CAG repeats. DNA Repair 49, 26–32 (2017).
doi: 10.1016/j.dnarep.2016.10.003 pubmed: 27865706 pmcid: 27865706
Gao, R. et al. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur. J. Hum. Genet. 16, 215–222 (2008).
doi: 10.1038/sj.ejhg.5201954 pubmed: 18043721 pmcid: 18043721
Gallon, R. et al. A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes. Hum. Mutat. 40, 649–655 (2019).
doi: 10.1002/humu.23721 pubmed: 30740824 pmcid: 30740824
Keohavong, P., Xi, L. & Grant, S. G. Molecular analysis of mutations in the human HPRT gene. Methods Mol. Biol. 291, 161–170 (2005).
pubmed: 15502221 pmcid: 15502221
Keohavong, P., Xi, L. & Grant, S. G. Molecular analysis of mutations in the human HPRT gene. Methods Mol. Biol. 1105, 291–301 (2014).
doi: 10.1007/978-1-62703-739-6_23 pubmed: 24623237 pmcid: 24623237
Albertini, R. J. et al. Mutagenicity monitoring following battlefield exposures: longitudinal study of HPRT mutations in Gulf War I veterans exposed to depleted uranium. Environ. Mol. Mutagen. 56, 581–593 (2015).
doi: 10.1002/em.21955 pubmed: 25914368 pmcid: 25914368
Nicklas, J. A. et al. Mutagenicity monitoring following battlefield exposures: molecular analysis of HPRT mutations in Gulf War I veterans exposed to depleted uranium. Environ. Mol. Mutagen. 56, 594–608 (2015).
doi: 10.1002/em.21956 pubmed: 25914382 pmcid: 25914382
Poon, S. L., McPherson, J. R., Tan, P., Teh, B. T. & Rozen, S. G. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med. 6, 24 (2014).
doi: 10.1186/gm541 pubmed: 25031618 pmcid: 25031618
Behjati, S. et al. Mutational signatures of ionizing radiation in second malignancies. Nat. Commun. 7, 12605 (2016).
doi: 10.1038/ncomms12605 pubmed: 27615322 pmcid: 27615322
Phillips, D. H. Mutational spectra and mutational signatures: insights into cancer aetiology and mechanisms of DNA damage and repair. DNA Repair 71, 6–11 (2018).
doi: 10.1016/j.dnarep.2018.08.003 pubmed: 30236628 pmcid: 30236628
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Preprint at bioRxiv https://doi.org/10.1101/322859 (2019).
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836.e16 (2019).
doi: 10.1016/j.cell.2019.03.001 pubmed: 30982602 pmcid: 30982602
Behjati, S. et al. Genome sequencing of normal cells reveals developmental lineages and mutational processes. Nature 513, 422–425 (2014).
doi: 10.1038/nature13448 pubmed: 25043003 pmcid: 25043003
Rouhani, F. J. et al. Mutational history of a human cell lineage from somatic to induced pluripotent stem cells. PLoS Genet. 12, e1005932 (2016).
doi: 10.1371/journal.pgen.1005932 pubmed: 27054363 pmcid: 27054363
Shlien, A. et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nat. Genet. 47, 257–262 (2015).
doi: 10.1038/ng.3202 pubmed: 25642631 pmcid: 25642631
Chalmers, Z. R. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9, 34 (2017).
doi: 10.1186/s13073-017-0424-2 pubmed: 28420421 pmcid: 28420421
Campbell, B. B. et al. Comprehensive analysis of hypermutation in human cancer. Cell 171, 1042–1056.e10 (2017).
doi: 10.1016/j.cell.2017.09.048 pubmed: 29056344 pmcid: 29056344
Hodel, K. P. et al. Explosive mutation accumulation triggered by heterozygous human Pol epsilon proofreading-deficiency is driven by suppression of mismatch repair. eLife 7, e32692 (2018).
doi: 10.7554/eLife.32692 pubmed: 29488881 pmcid: 29488881
Rayner, E. et al. A panoply of errors: polymerase proofreading domain mutations in cancer. Nat. Rev. Cancer 16, 71–81 (2016).
doi: 10.1038/nrc.2015.12 pubmed: 26822575 pmcid: 26822575
Nakamori, M., Gourdon, G. & Thornton, C. A. Stabilization of expanded (CTG)·(CAG) repeats by antisense oligonucleotides. Mol. Ther. 19, 2222–2227 (2011).
doi: 10.1038/mt.2011.191 pubmed: 21971425 pmcid: 21971425
Su, X. A. & Freudenreich, C. H. Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 114, E8392–E8401 (2017).
doi: 10.1073/pnas.1711283114 pubmed: 28923949 pmcid: 28923949
Lin, Y., Hubert, L. Jr. & Wilson, J. H. Transcription destabilizes triplet repeats. Mol. Carcinog. 48, 350–361 (2009).
doi: 10.1002/mc.20488 pubmed: 18973172 pmcid: 18973172
Tomé, S. et al. MSH2 ATPase domain mutation affects CTG·CAG repeat instability in transgenic mice. PLoS Genet. 5, e1000482 (2009).
doi: 10.1371/journal.pgen.1000482 pubmed: 19436705 pmcid: 19436705
McMurray, C. T. Hijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease. DNA Repair 7, 1121–1134 (2008).
doi: 10.1016/j.dnarep.2008.03.013 pubmed: 18472310 pmcid: 18472310
Morales, F. et al. A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients. DNA Repair 40, 57–66 (2016).
doi: 10.1016/j.dnarep.2016.01.001 pubmed: 26994442 pmcid: 26994442
Flower, M. et al. MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1. Brain 142, 1876–1886 (2019).
doi: 10.1093/brain/awz115
Panigrahi, G. B., Lau, R., Montgomery, S. E., Leonard, M. R. & Pearson, C. E. Slipped (CTG)*(CAG) repeats can be correctly repaired, escape repair or undergo error-prone repair. Nat. Struct. Mol. Biol. 12, 654–662 (2005).
doi: 10.1038/nsmb959 pubmed: 16025129 pmcid: 16025129
Zhang, T., Huang, J., Gu, L. & Li, G. M. In vitro repair of DNA hairpins containing various numbers of CAG/CTG trinucleotide repeats. DNA Repair 11, 201–209 (2012).
doi: 10.1016/j.dnarep.2011.10.020 pubmed: 22041023 pmcid: 22041023
Lai, Y. et al. Crosstalk between MSH2–MSH3 and polβ promotes trinucleotide repeat expansion during base excision repair. Nat. Commun. 7, 12465 (2016).
doi: 10.1038/ncomms12465 pubmed: 27546332 pmcid: 27546332
Tian, L. et al. Mismatch recognition protein MutSβ does not hijack (CAG)n hairpin repair in vitro. J. Biol. Chem. 284, 20452–20456 (2009).
doi: 10.1074/jbc.C109.014977 pubmed: 19525234 pmcid: 19525234
Nakatani, R., Nakamori, M., Fujimura, H., Mochizuki, H. & Takahashi, M. P. Large expansion of CTG·CAG repeats is exacerbated by MutSβ in human cells. Sci. Rep. 5, 11020 (2015).
doi: 10.1038/srep11020 pubmed: 26047474 pmcid: 26047474
Chen, H., Lisby, M. & Symington, L. S. RPA coordinates DNA end resection and prevents formation of DNA hairpins. Mol. Cell 50, 589–600 (2013).
doi: 10.1016/j.molcel.2013.04.032 pubmed: 23706822 pmcid: 23706822
Nguyen, B. et al. Diffusion of human replication protein A along single-stranded DNA. J. Mol. Biol. 426, 3246–3261 (2014).
doi: 10.1016/j.jmb.2014.07.014 pubmed: 25058683 pmcid: 25058683
Tsurimoto, T. & Stillman, B. Multiple replication factors augment DNA synthesis by the two eukaryotic DNA polymerases, alpha and delta. EMBO J. 8, 3883–3889 (1989).
doi: 10.1002/j.1460-2075.1989.tb08567.x pubmed: 2573521 pmcid: 2573521
Tsurimoto, T. & Stillman, B. Replication factors required for SV40 DNA replication in vitro. I. DNA structure-specific recognition of a primer–template junction by eukaryotic DNA polymerases and their accessory proteins. J. Biol. Chem. 266, 1950–1960 (1991).
pubmed: 1671045 pmcid: 1671045
Chan, N. L. et al. The Werner syndrome protein promotes CAG/CTG repeat stability by resolving large (CAG)
doi: 10.1074/jbc.M112.389791 pubmed: 22787159 pmcid: 22787159
Callahan, J. L., Andrews, K. J., Zakian, V. A. & Freudenreich, C. H. Mutations in yeast replication proteins that increase CAG/CTG expansions also increase repeat fragility. Mol. Cell. Biol. 23, 7849–7860 (2003).
doi: 10.1128/MCB.23.21.7849-7860.2003 pubmed: 14560028 pmcid: 14560028
Raji, N. S., Krishna, T. H. & Rao, K. S. DNA-polymerase α, β, Δ and ε activities in isolated neuronal and astroglial cell fractions from developing and aging rat cerebral cortex. Int. J. Dev. Neurosci. 20, 491–496 (2002).
doi: 10.1016/S0736-5748(02)00079-5 pubmed: 12392752 pmcid: 12392752
Kovalenko, M. et al. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington’s disease knock-in mice. PLoS ONE 7, e44273 (2012).
doi: 10.1371/journal.pone.0044273 pubmed: 22970194 pmcid: 22970194
Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington’s disease mutation. Nat. Genet. 15, 197–200 (1997).
doi: 10.1038/ng0297-197 pubmed: 9020849 pmcid: 9020849
Chiang, C. et al. Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat. Genet. 44, 390–397 (2012).
doi: 10.1038/ng.2202 pubmed: 22388000 pmcid: 22388000
Larson, E., Fyfe, I., Morton, A. J. & Monckton, D. G. Age-, tissue- and length-dependent bidirectional somatic CAG·CTG repeat instability in an allelic series of R6/2 Huntington disease mice. Neurobiol. Dis. 76, 98–111 (2015).
doi: 10.1016/j.nbd.2015.01.004 pubmed: 25662336 pmcid: 25662336
Kennedy, L. & Shelbourne, P. F. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington’s disease? Hum. Mol. Genet. 9, 2539–2544 (2000).
doi: 10.1093/hmg/9.17.2539 pubmed: 11030759 pmcid: 11030759
Ishiguro, H. et al. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington’s disease gene. J. Neurosci. Res. 65, 289–297 (2001).
doi: 10.1002/jnr.1153 pubmed: 11494364 pmcid: 11494364
Gonitel, R. et al. DNA instability in postmitotic neurons. Proc. Natl Acad. Sci. USA 105, 3467–3472 (2008).
doi: 10.1073/pnas.0800048105 pubmed: 18299573 pmcid: 18299573
De Rooij, K. E., De Koning Gans, P. A., Roos, R. A., Van Ommen, G. J. & Den Dunnen, J. T. Somatic expansion of the (CAG)
doi: 10.1007/BF00225192 pubmed: 7868117 pmcid: 7868117
Lee, J. M., Pinto, R. M., Gillis, T., St Claire, J. C. & Wheeler, V. C. Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver. PLoS ONE 6, e23647 (2011).
doi: 10.1371/journal.pone.0023647 pubmed: 21897851 pmcid: 21897851
Lee, J. M. et al. A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst. Biol. 4, 29 (2010).
doi: 10.1186/1752-0509-4-29 pubmed: 20302627 pmcid: 20302627
Wheeler, V. C. et al. Factors associated with HD CAG repeat instability in Huntington disease. J. Med. Genet. 44, 695–701 (2007).
doi: 10.1136/jmg.2007.050930 pubmed: 17660463 pmcid: 17660463
Higham, C. F., Morales, F., Cobbold, C. A., Haydon, D. T. & Monckton, D. G. High levels of somatic DNA diversity at the myotonic dystrophy type 1 locus are driven by ultra-frequent expansion and contraction mutations. Hum. Mol. Genet. 21, 2450–2463 (2012).
doi: 10.1093/hmg/dds059 pubmed: 22367968 pmcid: 22367968
Veitch, N. J. et al. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease. DNA Repair 6, 789–796 (2007).
doi: 10.1016/j.dnarep.2007.01.002 pubmed: 17293170 pmcid: 17293170
Hornsby, P. J. & Didenko, V. V. In situ ligation: a decade and a half of experience. Methods Mol. Biol. 682, 49–63 (2011).
doi: 10.1007/978-1-60327-409-8_5 pubmed: 21057920 pmcid: 21057920
Majtnerova, P. & Rousar, T. An overview of apoptosis assays detecting DNA fragmentation. Mol. Biol. Rep. 45, 1469–1478 (2018).
doi: 10.1007/s11033-018-4258-9 pubmed: 30022463 pmcid: 30022463
Iannicola, C. et al. Early alterations in gene expression and cell morphology in a mouse model of Huntington’s disease. J. Neurochem. 75, 830–839 (2000).
doi: 10.1046/j.1471-4159.2000.0750830.x pubmed: 10899961 pmcid: 10899961
Turmaine, M. et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc. Natl Acad. Sci. USA 97, 8093–8097 (2000).
doi: 10.1073/pnas.110078997 pubmed: 10869421 pmcid: 10869421
Yu, Z. X. et al. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington’s disease. J. Neurosci. 23, 2193–2202 (2003).
doi: 10.1523/JNEUROSCI.23-06-02193.2003 pubmed: 12657678 pmcid: 12657678
DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).
doi: 10.1126/science.277.5334.1990 pubmed: 9302293 pmcid: 9302293
Li, S. H. & Li, X. J. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777–782 (1998).
doi: 10.1093/hmg/7.5.777 pubmed: 9536080 pmcid: 9536080
Becher, M. W. et al. Intranuclear neuronal inclusions in Huntington’s disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4, 387–397 (1998).
doi: 10.1006/nbdi.1998.0168 pubmed: 9666478 pmcid: 9666478
Li, H. et al. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington’s disease transgenic mice. Hum. Mol. Genet. 8, 1227–1236 (1999).
doi: 10.1093/hmg/8.7.1227 pubmed: 10369868 pmcid: 10369868
Li, H., Li, S. H., Johnston, H., Shelbourne, P. F. & Li, X. J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25, 385–389 (2000).
doi: 10.1038/78054 pubmed: 10932179 pmcid: 10932179
Carty, N. et al. Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington’s disease: an in vivo high-content imaging study. PLoS ONE 10, e0123527 (2015).
doi: 10.1371/journal.pone.0123527 pubmed: 25859666 pmcid: 25859666
Kaytor, M. D., Wilkinson, K. D. & Warren, S. T. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity. J. Neurochem. 89, 962–973 (2004).
doi: 10.1111/j.1471-4159.2004.02376.x pubmed: 15140195 pmcid: 15140195
Coufal, M. et al. Discovery of a novel small-molecule targeting selective clearance of mutant huntingtin fragments. J. Biomol. Screen. 12, 351–360 (2007).
doi: 10.1177/1087057107299428 pubmed: 17379859 pmcid: 17379859
Chopra, V. et al. A small-molecule therapeutic lead for Huntington’s disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse. Proc. Natl Acad. Sci. USA 104, 16685–16689 (2007).
doi: 10.1073/pnas.0707842104 pubmed: 17925440 pmcid: 17925440
Butler, D. C. & Messer, A. Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLoS ONE 6, e29199 (2011).
doi: 10.1371/journal.pone.0029199 pubmed: 22216210 pmcid: 22216210
Perucho, J. et al. Striatal infusion of glial conditioned medium diminishes huntingtin pathology in r6/1 mice. PLoS ONE 8, e73120 (2013).
doi: 10.1371/journal.pone.0073120 pubmed: 24069174 pmcid: 24069174
Tsvetkov, A. S. et al. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat. Chem. Biol. 9, 586–592 (2013).
doi: 10.1038/nchembio.1308 pubmed: 23873212 pmcid: 23873212
Penney, J. B. Jr, Vonsattel, J. P., MacDonald, M. E., Gusella, J. F. & Myers, R. H. CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann. Neurol. 41, 689–692 (1997).
doi: 10.1002/ana.410410521 pubmed: 9153534 pmcid: 9153534
Wheeler, V. C. et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 9, 503–513 (2000).
doi: 10.1093/hmg/9.4.503 pubmed: 10699173 pmcid: 10699173
Rosenblatt, A. et al. Does CAG repeat number predict the rate of pathological changes in Huntington’s disease? Ann. Neurol. 44, 708–709 (1998).
doi: 10.1002/ana.410440424 pubmed: 9778276 pmcid: 9778276
Wild, E. J. & Tabrizi, S. J. Therapies targeting DNA and RNA in Huntington’s disease. Lancet Neurol. 16, 837–847 (2017).
doi: 10.1016/S1474-4422(17)30280-6 pubmed: 28920889 pmcid: 28920889
Dabrowska, M., Juzwa, W., Krzyzosiak, W. J. & Olejniczak, M. Precise excision of the CAG tract from the Huntingtin gene by Cas9 nickases. Front. Neurosci. https://doi.org/10.3389/fnins.2018.00075 (2018).
Shin, J. W. et al. Permanent inactivation of Huntington’s disease mutation by personalized allele-specific CRISPR/Cas9. Hum. Mol. Genet. 25, 4566–4576 (2016).
pubmed: 28172889 pmcid: 28172889
Monteys, A. M., Ebanks, S. A., Keiser, M. S. & Davidson, B. L. CRISPR/Cas9 editing of the mutant huntingtin allele in vitro and in vivo. Mol. Ther. 25, 12–23 (2017).
doi: 10.1016/j.ymthe.2016.11.010 pubmed: 28129107 pmcid: 28129107
Cinesi, C., Aeschbach, L., Yang, B. & Dion, V. Contracting CAG/CTG repeats using the CRISPR–Cas9 nickase. Nat. Commun. 7, 13272 (2016).
doi: 10.1038/ncomms13272 pubmed: 27827362 pmcid: 27827362
Suelves, N., Kirkham-McCarthy, L., Lahue, R. S. & Gines, S. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington’s disease mice. Sci. Rep. 7, 6082 (2017).
doi: 10.1038/s41598-017-05125-2 pubmed: 28729730 pmcid: 28729730
Eisenstein, M. CRISPR takes on Huntington’s disease. Nature 557, S42–S43 (2018).
doi: 10.1038/d41586-018-05177-y pubmed: 29844549 pmcid: 29844549
Martins, S. et al. Modifiers of (CAG)
doi: 10.1007/s00439-014-1467-8 pubmed: 25026993 pmcid: 25026993
Guo, J., Gu, L., Leffak, M. & Li, G. M. MutSβ promotes trinucleotide repeat expansion by recruiting DNA polymerase β to nascent (CAG)
doi: 10.1038/cr.2016.66 pubmed: 27255792 pmcid: 27255792
Hanawalt, P. C. & Spivak, G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat. Rev. Mol. Cell Biol. 9, 958–970 (2008).
doi: 10.1038/nrm2549 pubmed: 19023283 pmcid: 19023283
Hou, C., Chan, N. L., Gu, L. & Li, G. M. Incision-dependent and error-free repair of (CAG)
doi: 10.1038/nsmb.1638 pubmed: 19597480 pmcid: 19597480
Chan, N. L. et al. Coordinated processing of 3′ slipped (CAG)
doi: 10.1074/jbc.M113.464370 pubmed: 23585564 pmcid: 23585564
Pinto, R. M. et al. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington’s disease mice: genome-wide and candidate approaches. PLoS Genet. 9, e1003930 (2013).
doi: 10.1371/journal.pgen.1003930 pubmed: 24204323 pmcid: 24204323
Wheeler, V. C. et al. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh
doi: 10.1093/hmg/ddg056 pubmed: 12554681 pmcid: 12554681
Strobel, S. A., Doucette-Stamm, L. A., Riba, L., Housman, D. E. & Dervan, P. B. Site-specific cleavage of human chromosome 4 mediated by triple-helix formation. Science 254, 1639–1642 (1991).
doi: 10.1126/science.1836279 pubmed: 1836279 pmcid: 1836279
Mittelman, D. et al. Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cells. Proc. Natl Acad. Sci. USA 106, 9607–9612 (2009).
doi: 10.1073/pnas.0902420106 pubmed: 19482946 pmcid: 19482946
Zeitler, B. et al. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease. Nat. Med. 25, 1131–1142 (2019).
doi: 10.1038/s41591-019-0478-3 pubmed: 31263285 pmcid: 31263285
Mosbach, V., Poggi, L. & Richard, G. F. Trinucleotide repeat instability during double-strand break repair: from mechanisms to gene therapy. Curr. Genet. 65, 17–28 (2019).
doi: 10.1007/s00294-018-0865-1 pubmed: 29974202 pmcid: 29974202
Malankhanova, T. B., Malakhova, A. A., Medvedev, S. P. & Zakian, S. M. Modern genome editing technologies in Huntington’s disease research. J. Huntington’s Dis. 6, 19–31 (2017).
doi: 10.3233/JHD-160222
Babacic, H., Mehta, A., Merkel, O. & Schoser, B. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: a systematic review. PLoS ONE 14, e0212198 (2019).
doi: 10.1371/journal.pone.0212198 pubmed: 30794581 pmcid: 30794581
Gomes-Pereira, M. & Monckton, D. G. Chemical modifiers of unstable expanded simple sequence repeats: what goes up, could come down. Mutat. Res. 598, 15–34 (2006).
doi: 10.1016/j.mrfmmm.2006.01.011 pubmed: 16500684 pmcid: 16500684
Pineiro, E. et al. Mutagenic stress modulates the dynamics of CTG repeat instability associated with myotonic dystrophy type 1. Nucleic Acids Res. 31, 6733–6740 (2003).
doi: 10.1093/nar/gkg898 pubmed: 14627806 pmcid: 14627806
Budworth, H. et al. Suppression of somatic expansion delays the onset of pathophysiology in a mouse model of Huntington’s disease. PLoS Genet. 11, e1005267 (2015).
doi: 10.1371/journal.pgen.1005267 pubmed: 26247199 pmcid: 26247199
Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E. & Dervan, P. B. Regulation of gene expression by small molecules. Nature 387, 202–205 (1997).
doi: 10.1038/387202a0 pubmed: 9144294 pmcid: 9144294
Leontieva, O. V. & Blagosklonny, M. V. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion. Cell Cycle 12, 3063–3069 (2013).
doi: 10.4161/cc.26130 pubmed: 23974099 pmcid: 23974099
Nakamori, M., Sobczak, K., Moxley, R. T. & Thornton, C. A. Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2. Neuromuscul. Disord. 19, 759–762 (2009).
doi: 10.1016/j.nmd.2009.07.012 pubmed: 19713112 pmcid: 19713112
Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69, 385 (1992).
pubmed: 1568252 pmcid: 1568252
Dietmaier, W. et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57, 4749–4756 (1997).
pubmed: 9354436 pmcid: 9354436
Kabbarah, O. et al. A panel of repeat markers for detection of microsatellite instability in murine tumors. Mol. Carcinog. 38, 155–159 (2003).
doi: 10.1002/mc.10157 pubmed: 14639654 pmcid: 14639654
Koob, M. D. et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 21, 379–384 (1999).
doi: 10.1038/7710 pubmed: 10192387 pmcid: 10192387
Kremer, B. et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am. J. Hum. Genet. 57, 343–350 (1995).
pubmed: 7668260 pmcid: 7668260
Cleary, J. D., Nichol, K., Wang, Y. H. & Pearson, C. E. Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat. Genet. 31, 37–46 (2002).
doi: 10.1038/ng870 pubmed: 11967533 pmcid: 11967533
Panigrahi, G. B., Cleary, J. D. & Pearson, C. E. In vitro (CTG)*(CAG) expansions and deletions by human cell extracts. J. Biol. Chem. 277, 13926–13934 (2002).
doi: 10.1074/jbc.M109761200 pubmed: 11832482 pmcid: 11832482
Reddy, K. et al. Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res. 39, 1749–1762 (2011).
doi: 10.1093/nar/gkq935 pubmed: 21051337 pmcid: 21051337
Binz, S. K., Dickson, A. M., Haring, S. J. & Wold, M. S. Functional assays for replication protein A (RPA). Methods Enzymol. 409, 11–38 (2006).
doi: 10.1016/S0076-6879(05)09002-6 pubmed: 16793393 pmcid: 16793393
Zhou, Y., Meng, X., Zhang, S., Lee, E. Y. & Lee, M. Y. Characterization of human DNA polymerase delta and its subassemblies reconstituted by expression in the MultiBac system. PLoS ONE 7, e39156 (2012).
doi: 10.1371/journal.pone.0039156 pubmed: 22723953 pmcid: 22723953
Mason, A. C., Roy, R., Simmons, D. T. & Wold, M. S. Functions of alternative replication protein A in initiation and elongation. Biochemistry 49, 5919–5928 (2010).
doi: 10.1021/bi100380n pubmed: 20545304 pmcid: 20545304
Tome, S. et al. Tissue-specific mismatch repair protein expression: MSH3 is higher than MSH6 in multiple mouse tissues. DNA Repair 12, 46–52 (2013).
doi: 10.1016/j.dnarep.2012.10.006 pubmed: 23228367 pmcid: 23228367
Jeon, I. et al. Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol. 132, 577–592 (2016).
doi: 10.1007/s00401-016-1582-9 pubmed: 27221146 pmcid: 27221146
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
doi: 10.1038/nbt.2514 pubmed: 23396013 pmcid: 23396013
Morgulis, A., Gertz, E. M., Schaffer, A. A. & Agarwala, R. A fast and symmetric DUST implementation to mask low-complexity DNA sequences. J. Comput. Biol. 13, 1028–1040 (2006).
doi: 10.1089/cmb.2006.13.1028 pubmed: 16796549 pmcid: 16796549
Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics 30, 2843–2851 (2014).
doi: 10.1093/bioinformatics/btu356 pubmed: 24974202 pmcid: 24974202
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
doi: 10.1038/nature12477 pubmed: 23945592 pmcid: 23945592
Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013).
doi: 10.1016/j.celrep.2012.12.008 pubmed: 23318258 pmcid: 23318258
Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54 (2016).
doi: 10.1038/nature17676 pubmed: 27135926 pmcid: 27135926
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics 26, 589–595 (2010).
doi: 10.1093/bioinformatics/btp698 pubmed: 20080505 pmcid: 20080505

Auteurs

Masayuki Nakamori (M)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Gagan B Panigrahi (GB)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Stella Lanni (S)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Terence Gall-Duncan (T)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Program of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Hideki Hayakawa (H)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Hana Tanaka (H)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Jennifer Luo (J)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Program of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Takahiro Otabe (T)

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Jinxing Li (J)

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Akihiro Sakata (A)

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Marie-Christine Caron (MC)

Genome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Quebec, Quebec, Canada.

Niraj Joshi (N)

Genome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Quebec, Quebec, Canada.

Tanya Prasolava (T)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Karen Chiang (K)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.
Program of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Jean-Yves Masson (JY)

Genome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Quebec, Quebec, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Quebec, Quebec, Canada.

Marc S Wold (MS)

Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Xiaoxiao Wang (X)

Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.

Marietta Y W T Lee (MYWT)

Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, USA.

John Huddleston (J)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.

Katherine M Munson (KM)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.

Scott Davidson (S)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Mehdi Layeghifard (M)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Lisa-Monique Edward (LM)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Richard Gallon (R)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.

Mauro Santibanez-Koref (M)

Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.

Asako Murata (A)

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Masanori P Takahashi (MP)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Evan E Eichler (EE)

Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.

Adam Shlien (A)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada.

Kazuhiko Nakatani (K)

Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Hideki Mochizuki (H)

Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Christopher E Pearson (CE)

Program of Genetics & Genome Biology, The Hospital for Sick Children, The Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada. cepearson.sickkids@gmail.com.
Program of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. cepearson.sickkids@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH